Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia.

Stan AD, Ghose S, Zhao C, Hulsey K, Mihalakos P, Yanagi M, Morris SU, Bartko JJ, Choi C, Tamminga CA.

Mol Psychiatry. 2015 Apr;20(4):433-9. doi: 10.1038/mp.2014.54. Epub 2014 Jun 10.

PMID:
24912493
2.

Toxoplasma gondii and other risk factors for schizophrenia: an update.

Torrey EF, Bartko JJ, Yolken RH.

Schizophr Bull. 2012 May;38(3):642-7. doi: 10.1093/schbul/sbs043. Epub 2012 Mar 23.

3.

Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale.

Allen MH, Daniel DG, Revicki DA, Canuso CM, Turkoz I, Fu DJ, Alphs L, Ishak KJ, Bartko JJ, Lindenmayer JP.

Innov Clin Neurosci. 2012 Jan;9(1):15-24.

4.

Training for assessment of negative symptoms of schizophrenia across languages and cultures: comparison of the NSA-16 with the PANSS Negative Subscale and Negative Symptom factor.

Daniel DG, Alphs L, Cazorla P, Bartko JJ, Panagides J.

Clin Schizophr Relat Psychoses. 2011 Jul;5(2):87-94. doi: 10.3371/CSRP.5.2.5.

PMID:
21693432
5.

The correlation of alcohol consumption with schizophrenia hospitalizations: 1934 to 2005.

Cawood FW, Bartko JJ.

Schizophr Res. 2009 Jun;111(1-3):194-5. doi: 10.1016/j.schres.2009.02.018. Epub 2009 Apr 1. No abstract available.

PMID:
19342200
6.

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use.

Pickar D, Vinik J, Bartko JJ.

PLoS One. 2008 Sep 10;3(9):e3150. doi: 10.1371/journal.pone.0003150.

7.

A cross-sectional evaluation of perimenopausal depression.

Steinberg EM, Rubinow DR, Bartko JJ, Fortinsky PM, Haq N, Thompson K, Schmidt PJ.

J Clin Psychiatry. 2008 Jun;69(6):973-80.

8.

The Ab-Adductometer: a new device for measuring the muscle strength and function of the thumb.

Rozmaryn LM, Bartko JJ, Isler ML.

J Hand Ther. 2007 Oct-Dec;20(4):311-24; quiz 325.

PMID:
17954352
9.

Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis.

Torrey EF, Bartko JJ, Lun ZR, Yolken RH.

Schizophr Bull. 2007 May;33(3):729-36. Epub 2006 Nov 3.

10.

First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS).

Herrell R, Henter ID, Mojtabai R, Bartko JJ, Venable D, Susser E, Merikangas KR, Wyatt RJ.

Psychol Med. 2006 Oct;36(10):1405-15. Epub 2006 Jul 31.

11.

The ipsilateral silent period in boys with attention-deficit/hyperactivity disorder.

Garvey MA, Barker CA, Bartko JJ, Denckla MB, Wassermann EM, Castellanos FX, Dell ML, Ziemann U.

Clin Neurophysiol. 2005 Aug;116(8):1889-96.

PMID:
15979402
12.

Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.

Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB.

Biol Psychiatry. 2005 Feb 1;57(3):252-60.

PMID:
15691526
13.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
14.

Seasonal variation in mood in African American college students in the Washington, D.C., metropolitan area.

Agumadu CO, Yousufi SM, Malik IS, Nguyen MC, Jackson MA, Soleymani K, Thrower CM, Peterman MJ, Walters GW, Niemtzoff MJ, Bartko JJ, Postolache TT.

Am J Psychiatry. 2004 Jun;161(6):1084-9.

PMID:
15169697
15.

Cortical correlates of neuromotor development in healthy children.

Garvey MA, Ziemann U, Bartko JJ, Denckla MB, Barker CA, Wassermann EM.

Clin Neurophysiol. 2003 Sep;114(9):1662-70.

PMID:
12948795
17.

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.

Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, Bergeson J, Manetti GJ, Zimmermann M, Tang B, Bartko JJ, Cohen RM.

JAMA. 2003 Apr 23-30;289(16):2094-103. Erratum in: JAMA. 2007 Oct 3;298(13):1516.

PMID:
12709467
18.

Height, weight and body mass index (BMI) in psychiatrically ill US Armed Forces personnel.

Wyatt RJ, Henter ID, Mojtabai R, Bartko JJ.

Psychol Med. 2003 Feb;33(2):363-8.

19.

Patients with seasonal affective disorder have lower odor detection thresholds than control subjects.

Postolache TT, Wehr TA, Doty RL, Sher L, Turner EH, Bartko JJ, Rosenthal NE.

Arch Gen Psychiatry. 2002 Dec;59(12):1119-22.

PMID:
12470128
20.
21.

Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.

Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, Buchanan RW.

Am J Psychiatry. 2002 May;159(5):838-44.

PMID:
11986139
22.

Subjective reactions of children to single-pulse transcranial magnetic stimulation.

Garvey MA, Kaczynski KJ, Becker DA, Bartko JJ.

J Child Neurol. 2001 Dec;16(12):891-4.

PMID:
11785502
23.

Adverse events during a placebo phase for inpatients with chronic schizophrenia.

van de Laar N, Henter I, Bartko JJ, Wyatt RJ.

Biol Psychiatry. 2001 Oct 1;50(7):487-92.

PMID:
11600101
24.

Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.

Knable MB, Torrey EF, Webster MJ, Bartko JJ.

Brain Res Bull. 2001 Jul 15;55(5):651-9.

PMID:
11576762
25.

New graphical method to measure silent periods evoked by transcranial magnetic stimulation.

Garvey MA, Ziemann U, Becker DA, Barker CA, Bartko JJ.

Clin Neurophysiol. 2001 Aug;112(8):1451-60.

PMID:
11459685
26.

Schizophrenia and season of birth in a tropical region: relationship to rainfall.

de Messias EL, Cordeiro NF, Sampaio JJ, Bartko JJ, Kirkpatrick B.

Schizophr Res. 2001 Mar 30;48(2-3):227-34.

PMID:
11295376
27.

Decisional capacity for informed consent in schizophrenia research.

Carpenter WT Jr, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS.

Arch Gen Psychiatry. 2000 Jun;57(6):533-8.

PMID:
10839330
28.

Penny-wise and pound-foolish: the impact of measurement error on sample size requirements in clinical trials.

Perkins DO, Wyatt RJ, Bartko JJ.

Biol Psychiatry. 2000 Apr 15;47(8):762-6.

PMID:
10773186
29.

Pupillary diameter assessment: need for a graded scale.

Litvan I, Saposnik G, Mauriño J, Gonzalez L, Saizar R, Sica RE, Bartko JJ.

Neurology. 2000 Jan 25;54(2):530-1. No abstract available.

PMID:
10668738
31.

A dose-outcome analysis of risperidone.

Love RC, Conley RR, Kelly DL, Bartko JJ.

J Clin Psychiatry. 1999 Nov;60(11):771-5.

PMID:
10584767
32.

The long-term effects of placebo in patients with chronic schizophrenia.

Wyatt RJ, Henter ID, Bartko JJ.

Biol Psychiatry. 1999 Oct 15;46(8):1092-105.

33.

Prediction of neuropsychological performance by neurological signs in schizophrenia.

Arango C, Bartko JJ, Gold JM, Buchanan RW.

Am J Psychiatry. 1999 Sep;156(9):1349-57.

PMID:
10484944
34.

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

Conley RR, Love RC, Kelly DL, Bartko JJ.

Am J Psychiatry. 1999 Jun;156(6):863-8.

PMID:
10360124
35.

Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study.

Litvan I I, Jankovic J, Goetz CG, Wenning GK, Sastry N, Jellinger K, McKee A, Lai EC, Brandel JP, Verny M, Ray-Chaudhuri K, Pearce RK, Bartko JJ, Agid Y.

Eur J Neurol. 1998 Sep;5(5):451-457.

PMID:
10210873
36.

Multinational neuropsychological testing: performance of children and adults.

Levav M, Mirsky AF, French LM, Bartko JJ.

J Clin Exp Neuropsychol. 1998 Oct;20(5):658-72.

PMID:
10079042
37.

Nerve and tendon gliding exercises and the conservative management of carpal tunnel syndrome.

Rozmaryn LM, Dovelle S, Rothman ER, Gorman K, Olvey KM, Bartko JJ.

J Hand Ther. 1998 Jul-Sep;11(3):171-9.

PMID:
9730093
38.

The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia.

Ross DE, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Compton AD, Thaker GK.

Schizophr Res. 1998 May 25;31(2-3):141-50.

PMID:
9689718
39.

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y.

Arch Neurol. 1998 Jul;55(7):969-78.

PMID:
9678315
40.

Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy.

Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y.

J Neural Transm (Vienna). 1998;105(2-3):217-27.

PMID:
9660099
41.

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S.

Am J Psychiatry. 1998 Jul;155(7):914-20.

PMID:
9659857
42.

Pilot study on patients' and spouses' attitudes toward potential genetic testing for bipolar disorder.

Trippitelli CL, Jamison KR, Folstein MF, Bartko JJ, DePaulo JR.

Am J Psychiatry. 1998 Jul;155(7):899-904.

PMID:
9659854
43.

Lack of seasonal variation of symptoms in patients with chronic fatigue syndrome.

García-Borreguero D, Dale JK, Rosenthal NE, Chiara A, O'Fallon A, Bartko JJ, Straus SE.

Psychiatry Res. 1998 Feb 9;77(2):71-7.

PMID:
9541142
44.

Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome.

Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, Bartko JJ, Goodman J, Tien A.

Biol Psychiatry. 1997 Nov 1;42(9):781-96.

PMID:
9347127
45.

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study.

Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y.

Arch Neurol. 1997 Aug;54(8):937-44.

PMID:
9267967
46.

What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study.

Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ.

Neurology. 1997 Jul;49(1):62-9. Erratum in: Neurology 1997 Dec;49(6):1755. Sastrj N [corrected to Sastry N].

PMID:
9222171
47.

Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study.

Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ.

Neurology. 1997 Jan;48(1):119-25. Review.

PMID:
9008506
48.

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.

Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J.

Am J Psychiatry. 1996 Dec;153(12):1571-8.

PMID:
8942453
49.

Reliability of the NINDS Myotatic Reflex Scale.

Litvan I, Mangone CA, Werden W, Bueri JA, Estol CJ, Garcea DO, Rey RC, Sica RE, Hallett M, Bartko JJ.

Neurology. 1996 Oct;47(4):969-72.

PMID:
8857728
50.

Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients.

Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J.

Am J Psychiatry. 1996 Sep;153(9):1158-65.

PMID:
8780419

Supplemental Content

Loading ...
Support Center